An Unusual Case of Anaphylaxis After Fluorine-18-Labeled Fluorodeoxyglucose Injection

Nuclear Medicine and Molecular Imaging - Tập 47 Số 3 - Trang 201-204 - 2013
Dong Yun Lee1, Dong Kun Lee1, Hyouk‐Soo Kwon2, Woo Yeon Moon1, Jin Su1, Sang Ju Lee1, Seung Jun Oh1, Jin Sook Ryu1
1Department of Nuclear Medicine, University of Ulsan College of Medicine, Asan Medical Center, 86 Asanbyeongwon-gil, Songpa-gu, Seoul, 138-736, South Korea
2Division of Allergy and Clinical Immunology, Department of Internal Medicine, University of Ulsan College of Medicine, Asan Medical Center, Seoul, South Korea

Tóm tắt

Từ khóa


Tài liệu tham khảo

Silberstein EB. Prevalence of adverse reactions to positron emitting radiopharmaceuticals in nuclear medicine. Pharmacopeia Committee of the Society of Nuclear Medicine. J Nucl Med. 1998;39(12):2190–2.

Codreanu I, Dasanu CA, Weinstein GS, Divgi C. Fluorodeoxyglucose-induced allergic reaction: A case report. J Oncol Pharm Pract. 2013;19(1):86-8.

Balan KK, Choudhary AK, Balan A, Wishart G. Severe systemic reaction to (99 m)Tc-methylene diphosphonate: a case report. J Nucl Med Technol. 2003;31(2):76–8.

Chicken DW, Mansouri R, Ell PJ, Keshtgar MR. Allergy to technetium-labelled nanocolloidal albumin for sentinel node identification. Ann R Coll Surg Engl. 2007;89(2):W12–3.

Mujtaba B, Adenaike M, Yaganti V, Mujtaba N, Jain D. Anaphylactic reaction to Tc-99 m sestamibi (Cardiolite) during pharmacologic myocardial perfusion imaging. J Nucl Cardiol. 2007;14(2):256–8.

Thomson LE, Allman KC. Erythema multiforme reaction to sestamibi. J Nucl Med. 2001;42(3):534.

Brown SG, Mullins RJ, Gold MS. Anaphylaxis: diagnosis and management. Med J Aust. 2006;185(5):283–9.

Lieberman P. Epidemiology of anaphylaxis. Curr Opin Allergy Clin Immunol. 2008;8(4):316–20.

Lee JK, Vadas P. Anaphylaxis: mechanisms and management. Clin Exp Allergy. 2011;41(7):923–38.

Naranjo CA, Busto U, Sellers EM, Sandor P, Ruiz I, Roberts EA, et al. A method for estimating the probability of adverse drug reactions. Clin Pharmacol Ther. 1981;30(2):239–45.

Silberstein EB, Ryan J. Prevalence of adverse reactions in nuclear medicine. Pharmacopeia Committee of the Society of Nuclear Medicine. J Nucl Med. 1996;37(1):185–92.

Hjelstuen OK, Svadberg A, Olberg DE, Rosser M. Standardization of fluorine-18 manufacturing processes: new scientific challenges for PET. Eur J Pharm Biopharm. 2011;78(3):307–13.

Marengo M, Lodi F, Magi S, Cicoria G, Pancaldi D, Boschi S. Assessment of radionuclidic impurities in 2-[18F]fluoro-2-deoxy-d-glucose ([18F]FDG) routine production. Appl Radiat Isot. 2008;66(3):295–302.

Mosdzianowsk C, Lemaire C, Simoens F, Aerts J, Morelle JL, Luxen A. Epimerization study on [18f]FDG produced by an alkaline hydrolysis on solid support under stringent conditions. Appl Radiat Isot. 2002;56(6):871–5.

Dominguez-Ortega J, Martinez-Alonso JC, Dominguez-Ortega C, Fuentes MJ, Frades A, Fernandez-Colino T. Anaphylaxis to oral furosemide. Allergol Immunopathol (Madr). 2003;31(6):345–7.

Arnold JJ, Williams PM. Anaphylaxis: recognition and management. Am Fam Physician. 2011;84(10):1111–8.